Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aging

Showing results (471-480 of 8,443) with videos related to

Pageof 845
Sort By:
Aging|January 23, 2019
MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinomaWen Xiao, Xuegang Wang, Tao Wang, et al.
Aging|January 23, 2019
Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysisYi-Qun Jia, Bo Yang, Li-Ling Wen, et al.
Aging|December 28, 2019
A phenolic amide (LyA) isolated from the fruits of <i>Lycium barbarum</i> protects against cerebral ischemia-reperfusion injury via PKCε/Nrf2/HO-1 pathwayKai Gao, Meiyou Liu, Yi Ding, et al.
Aging|December 28, 2019
Macrophage migration inhibitory factor rejuvenates aged human mesenchymal stem cells and improves myocardial repairYuelin Zhang, Wenwu Zhu, Haiwei He, et al.
Aging|December 28, 2019
Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinomaZihao Pan, Jiatong Lin, Duoguang Wu, et al.
Aging|December 18, 2019
Age-related changes in eye lens biomechanics, morphology, refractive index and transparencyCatherine Cheng, Justin Parreno, Roberta B Nowak, et al.
Aging|December 19, 2019
Epigenetic mortality predictors and incidence of breast cancerJacob K Kresovich, Zongli Xu, Katie M O'Brien, et al.
Aging|December 19, 2019
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signalingShiyi Yu, Meng Zhang, Ling Huang, et al.
Aging|December 19, 2019
Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patientsJian-Feng Yang, Shen-Nan Shi, Wen-Hao Xu, et al.
Aging|December 17, 2019
Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritisXiaojian Huang, Bowei Ni, Yang Xi, et al.
Pageof 845

Showing results (471-480 of 8,443) with videos related to

Sort By:
Pageof 845
Aging|January 23, 2019
MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinomaWen Xiao, Xuegang Wang, Tao Wang, et al.
Aging|January 23, 2019
Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysisYi-Qun Jia, Bo Yang, Li-Ling Wen, et al.
Aging|December 28, 2019
A phenolic amide (LyA) isolated from the fruits of <i>Lycium barbarum</i> protects against cerebral ischemia-reperfusion injury via PKCε/Nrf2/HO-1 pathwayKai Gao, Meiyou Liu, Yi Ding, et al.
Aging|December 28, 2019
Macrophage migration inhibitory factor rejuvenates aged human mesenchymal stem cells and improves myocardial repairYuelin Zhang, Wenwu Zhu, Haiwei He, et al.
Aging|December 28, 2019
Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinomaZihao Pan, Jiatong Lin, Duoguang Wu, et al.
Aging|December 18, 2019
Age-related changes in eye lens biomechanics, morphology, refractive index and transparencyCatherine Cheng, Justin Parreno, Roberta B Nowak, et al.
Aging|December 19, 2019
Epigenetic mortality predictors and incidence of breast cancerJacob K Kresovich, Zongli Xu, Katie M O'Brien, et al.
Aging|December 19, 2019
ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signalingShiyi Yu, Meng Zhang, Ling Huang, et al.
Aging|December 19, 2019
Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patientsJian-Feng Yang, Shen-Nan Shi, Wen-Hao Xu, et al.
Aging|December 17, 2019
Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritisXiaojian Huang, Bowei Ni, Yang Xi, et al.
Pageof 845